Showing results (3241-3250 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|June 13, 2019
Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor TherapyXuelin Dou, Yazhen Qin, Xiaojun Huang, et al.
The Oncologist|June 29, 2019
FGFR2-Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic LandscapeSamuel J Klempner, Russell Madison, Vivek Pujara, et al.
The Oncologist|May 26, 2019
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR InhibitorsJih-Hsiang Lee, Hsuan-Yu Chen, Feng-Ming Hsu, et al.
The Oncologist|June 14, 2019
TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real WorldJonathan Strosberg, Vijay N Joish, Susan Giacalone, et al.
The Oncologist|June 24, 2018
Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast CancerMarie Lange, Natacha Heutte, Sabine Noal, et al.
The Oncologist|June 24, 2018
Barriers and Facilitators to Cervical Cancer Screening, Diagnosis, Follow-Up Care and Treatment: Perspectives of Human Immunodeficiency Virus-Positive Women and Health Care Practitioners in TanzaniaLori Brand Bateman, Shaundra Blakemore, Alaya Koneru, et al.
The Oncologist|June 24, 2018
Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with NivolumabYukihiro Toi, Shunichi Sugawara, Yosuke Kawashima, et al.
The Oncologist|June 1, 2019
Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal CancerMichael A Morse, Michael J Overman, Leighanne Hartman, et al.
The Oncologist|June 1, 2019
The Development of an International Oncofertility Competency Framework: A Model to Increase Oncofertility ImplementationAntoinette Anazodo, Paula Laws, Shanna Logan, et al.
The Oncologist|June 2, 2019
Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate CancerElisabeth Heath, Lance Heilbrun, Heather Mannuel, et al.
Pageof 571